Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.

Xu Q, Zhang L, Duan X, Zhou K, Li Z, Yang X, Wang J, Jiang J, Xu K, Yu G, Zheng P, Li Y, Qin X, Li J, Wang WY, Zhao H, Huang D, Qu H, Xiao H, Li B, Wu L, Feng J.